Biora Therapeutics, Inc. Accounts Payable
Biora Therapeutics, Inc. had Accounts Payable of $6.92 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2024-11-14
- 2024-09-30: Accounts Payable, Current $6.92M.
- 2024-06-30: Accounts Payable, Current $7.51M.
- 2024-03-31: Accounts Payable, Current $4.94M.
- 2023-12-31: Accounts Payable, Current $2.84M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2024-09-30 | $6.92M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $7.51M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $4.94M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $2.84M 10-Q · filed 2024-11-14 | |
| 2023-09-30 | $3.90M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $5.04M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $3.42M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $3.61M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $2.36M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $4.32M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $5.38M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $8.71M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $7.99M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $14.56M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $15.63M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $17.38M 10-K · filed 2022-03-28 | $17.41M 10-K · filed 2021-03-18 |
| 2020-09-30 | $15.67M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $15.68M 10-Q · filed 2020-08-14 | |
| 2019-12-31 | $15.75M 10-K · filed 2021-03-18 |